PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 31 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,241 | -44.7% | 1,434 | -44.9% | 0.00% | – |
| Q2 2023 | $13,088 | +118881.8% | 2,602 | +47.2% | 0.00% | – |
| Q1 2023 | $11 | -63.3% | 1,768 | -22.3% | 0.00% | -100.0% |
| Q4 2022 | $30 | -99.9% | 2,274 | -83.7% | 0.00% | 0.0% |
| Q3 2022 | $42,000 | +4100.0% | 13,991 | +11183.1% | 0.00% | – |
| Q1 2022 | $1,000 | -98.8% | 124 | -98.8% | 0.00% | -100.0% |
| Q4 2021 | $80,000 | -70.3% | 9,921 | -44.9% | 0.00% | -85.7% |
| Q3 2021 | $269,000 | +572.5% | 17,997 | +464.0% | 0.01% | +600.0% |
| Q2 2021 | $40,000 | -62.6% | 3,191 | -86.4% | 0.00% | -50.0% |
| Q1 2021 | $107,000 | +1683.3% | 23,447 | +763.0% | 0.00% | – |
| Q3 2020 | $6,000 | +100.0% | 2,717 | +634.3% | 0.00% | – |
| Q1 2019 | $3,000 | – | 370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
| AMUSSEN HUNSAKER ASSOCIATES LLC | 75,016 | $377,330 | 0.08% |
| Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
| Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
| Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
| LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
| WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
| Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |